JP2024513949A5 - - Google Patents

Info

Publication number
JP2024513949A5
JP2024513949A5 JP2023562535A JP2023562535A JP2024513949A5 JP 2024513949 A5 JP2024513949 A5 JP 2024513949A5 JP 2023562535 A JP2023562535 A JP 2023562535A JP 2023562535 A JP2023562535 A JP 2023562535A JP 2024513949 A5 JP2024513949 A5 JP 2024513949A5
Authority
JP
Japan
Prior art keywords
seq
sequence
aav capsid
capsid protein
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023562535A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024513949A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/024603 external-priority patent/WO2022221400A2/en
Publication of JP2024513949A publication Critical patent/JP2024513949A/ja
Publication of JP2024513949A5 publication Critical patent/JP2024513949A5/ja
Pending legal-status Critical Current

Links

JP2023562535A 2021-04-13 2022-04-13 脳内発現レベルが高いaav組成物 Pending JP2024513949A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163174434P 2021-04-13 2021-04-13
US63/174,434 2021-04-13
PCT/US2022/024603 WO2022221400A2 (en) 2021-04-13 2022-04-13 Aav compositions having high expression levels in brain

Publications (2)

Publication Number Publication Date
JP2024513949A JP2024513949A (ja) 2024-03-27
JP2024513949A5 true JP2024513949A5 (cg-RX-API-DMAC7.html) 2025-04-18

Family

ID=83641102

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023562535A Pending JP2024513949A (ja) 2021-04-13 2022-04-13 脳内発現レベルが高いaav組成物

Country Status (8)

Country Link
US (1) US20240150410A1 (cg-RX-API-DMAC7.html)
EP (1) EP4322976A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024513949A (cg-RX-API-DMAC7.html)
KR (1) KR20240028976A (cg-RX-API-DMAC7.html)
CN (1) CN117440820A (cg-RX-API-DMAC7.html)
AU (1) AU2022258447A1 (cg-RX-API-DMAC7.html)
CA (1) CA3216172A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022221400A2 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016523835A (ja) * 2013-05-15 2016-08-12 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ 中枢神経系へのアデノ随伴ウイルスを介した遺伝子導入
CN113166208B (zh) 2018-10-02 2024-11-22 沃雅戈治疗公司 重新定向aav衣壳的嗜性
US12630842B2 (en) 2020-05-13 2026-05-19 Voyager Therapeutics, Inc. Redirection of tropism of AAV capsids
KR20240095539A (ko) 2021-10-08 2024-06-25 디노 테라퓨틱스, 인코포레이티드 캡시드 변이체 및 이의 사용 방법
EP4426716A1 (en) 2021-11-02 2024-09-11 Voyager Therapeutics, Inc. Aav capsid variants and uses thereof
JP2026509271A (ja) 2023-03-10 2026-03-17 ダイノ セラピューティクス,インコーポレーテッド カプシドポリペプチドおよびその使用方法
TW202515898A (zh) 2023-06-30 2025-04-16 日商武田藥品工業股份有限公司 Htt抑制物及其用途
KR20260082361A (ko) 2023-08-31 2026-06-04 디노 테라퓨틱스, 인코포레이티드 캡시드 폴리펩타이드 및 이의 사용 방법
TW202545971A (zh) 2024-02-08 2025-12-01 美商戴諾治療公司 殼體多肽及其使用方法
WO2026064442A2 (en) 2024-09-18 2026-03-26 Dyno Therapeutics, Inc. Capsid polypeptides and methods of use thereof
WO2026122963A1 (en) 2024-12-06 2026-06-11 Dyno Therapeutics, Inc. Capsid polypeptides and methods of use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110166335A1 (en) * 2000-06-30 2011-07-07 Corbin David R Xenorhabdus sp. genome sequences and uses thereof
EP2741772A1 (en) * 2011-08-08 2014-06-18 ETH Zurich Pasteurellaceae vaccines
KR20250023600A (ko) * 2017-06-30 2025-02-18 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 변이체 캡시드를 보유한 아데노-부속 바이러스 비리온 및 이의 사용 방법
SG11202111249YA (en) * 2019-04-11 2021-11-29 California Inst Of Techn Virus compositions with enhanced specificity in the brain
WO2022040530A2 (en) * 2020-08-21 2022-02-24 Capsida, Inc. Virus compositions for treating mucopolysaccharidosis ii
EP4199972A4 (en) * 2020-08-21 2025-01-15 Capsida, Inc. ADENO-ASSOCIATED VIRUS COMPOSITIONS WITH PREFERRED EXPRESSION LEVELS

Similar Documents

Publication Publication Date Title
JP2022526018A5 (cg-RX-API-DMAC7.html)
JP6387350B2 (ja) 希突起神経膠細胞を標的とするアデノ随伴ウイルスベクター
JP2025179046A5 (cg-RX-API-DMAC7.html)
JP2023538129A5 (cg-RX-API-DMAC7.html)
TW202134260A (zh) 微小肌縮蛋白基因療法之構築體及其用途
ES2685611T3 (es) Vector VAA8 mejorado con una actividad funcional aumentada y métodos de utilización del mismo
JP2022531809A (ja) ATPase媒介性疾患の処置のための組成物および方法
TW202328446A (zh) 肌肉萎縮症之治療
JP2023500011A5 (cg-RX-API-DMAC7.html)
JP7707081B2 (ja) 網膜細胞を標的とした最適化された遺伝子治療
CN111163811A (zh) 重组腺相关载体
JP2024543211A5 (cg-RX-API-DMAC7.html)
CN113574176A (zh) 腺相关病毒对cln6多核苷酸的递送
JP2024515626A5 (cg-RX-API-DMAC7.html)
CA3178591A1 (en) Immunosuppressive agents and viral delivery re-dosing methods for gene therapy
CN114516901B (zh) 一种神经系统高亲和性的aav载体及其应用
WO2023111106A1 (en) Fukutin related protein gene transfer increase using modified itr sequences
US20250325703A1 (en) Composition for delivering gene to brain tissue and use thereof
JP2023545384A5 (cg-RX-API-DMAC7.html)
CN116179605B (zh) 一种重组腺相关病毒载体及其应用
JP7826334B2 (ja) 髄腔内送達によってピット・ホプキンス症候群を治療するためのメチル-cpg結合タンパク質2をコードする組換えアデノ随伴ウイルス
EP4198046A1 (en) Alpha-sarcoglycan gene transfer increase using modified itr sequences
CN121758632A (zh) 靶向肌肉的腺相关病毒衣壳蛋白、包含其的腺相关病毒、载体及应用
HK40063258A (zh) 腺相关病毒对cln6多核苷酸的递送
HK40063258B (en) Adeno-associated virus delivery of cln6 polynucleotide